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regressionAbstract This study, for the ﬁrst time, applies multivariate spectrophotometric calibration for
simultaneous determination of three pyrimidine bases including uracil (URA), cytosine (CYT)
and thymine (THY). Although determination of these bases is of great importance from a physio-
logical and pharmaceutical perspective, it could be a difﬁcult task since there is some sort of spectral
overlapping. The principal component regression (PCR) and partial least-squares (PLS) model were
used to overcome this problem and to construct the calibration sets containing URA, CYT and
THY in the concentration range of 1.12–22.42, 1.11–27.78 and 1.26–25.22 lg mL1, respectively.
The absorption spectra were recorded from 220–320 nm. The results showed that the NPCs for
URA, CYT and THY were 6, 5 and 4 by PCR and 4, 5 and 3 by PLS, respectively. In addition,
the RMSEPs for URA, CYT and THY were 0.7067, 0.5093 and 0.6371 by PCR and 0.5469,
0.2700 and 0.5087 by PLS, respectively. The proposed method yielded recoveries ranging from
93.85 to 107.45 by PLS and 90.48 to 111.42 by PCR. The method was successful in simultaneous
determination of the three bases in urine, serum and plasma.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Pyrimidine bases are the building blocks in both DNA and
RNA which in turn play important roles in cell metabolism.
Base changes in DNA may seriously affect the structure andfunction of products of gene expression protein, which is con-
sidered the main cause of inherited diseases and most human
cancers (Vnencak-Jones, 1999; Lane, 1999; Lindblom and
Nordenskjold, 1999). Among the pyrimidine bases, uracil
(URA), cytosine (CYT) and thymine (THY) can be mentioned.
URA, a common and naturally occurring pyrimidine deriv-
ative (Garrett and Grisham, 1997), originally was discovered in
1900 and was isolated by hydrolysis of yeast nuclein that was
found in bovine thymus and spleen, herring, sperm, and wheat
germ (Brown, 1994). URA can be used for drug delivery and
also as a pharmaceutical drug. URA is used in the body to help
carry out the synthesis of many enzymes necessary for cell
functions through bonding with riboses and phosphates
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tor and coenzyme for reactions in the human body and in
plants. URA is also involved in the biosynthesis of polysaccha-
rides and the transportation of sugars containing aldehydes
(Brown, 1998). It can also increase the risk for cancer in cases
where the body is deﬁcient in folate (Mashiyama et al., 2004).
URA derivatives containing a diazine ring are used in pesti-
cides (Pozharskii et al., 1997).
CYT is one of the ﬁve main bases found in DNA and RNA.
It is a pyrimidine derivative with a heterocyclic ring and two
substituents attached (an amine group at position 4 and a keto
group at position 2) (Kossel and Steudel, 1903). Recently,
CYT has been used in quantum computation. CYT can be
found as a part of DNA, RNA, or a nucleotide.
THY is one of the four bases in the nucleic acid of DNA
and it is also known as 5-methyluracil. THY may be derived
by methylation of URA at the 5th carbon. THY could also
be a target for actions of 5-ﬂuorouracil (5-FU) in cancer treat-
ment. 5-FU can be a metabolic analog of THY (in DNA syn-
thesis) or URA (in RNA synthesis). THY bases are often
oxidized to hydantoins over time after the death of an organ-
ism (Hofreiter et al., 2001).
Many areas such as pharmacological studies, clinical diag-
nosis and DNA damage assay need a quick, inexpensive and
accurate method for the determination of pyrimidine bases
(Cadet and Weinfeld, 1993; Tseng et al., 1994; Lin et al.,
1997; Ames, 1998; Atamna et al., 2000; Ames and Acad,
1999). Because of the central biological signiﬁcance of nucleic
acids, it is important to know as much as possible about their
function, their structure, and their chemical composition.
High performance liquid chromatography (HPLC) is a
commonly used method for the analysis of pyrimidine bases
(Perrett and Simmonds, 1990; Grune et al., 1993; Minniti
et al., 1998). Capillary electrophoresis (CE) is a powerful alter-
native to HPLC for the separation of charged and polar com-
pounds (Yang et al., 1997; Altria, 1999; Fritz, 2000; Krylov
and Dovichi, 2000). CE has been successfully used for the anal-
ysis of nucleic acids and nucleotides because they are nega-
tively charged in neutral pH buffer (Boyce, 2001; Cohen
et al., 1987; Deforce et al., 1996; Geldart and Brown, 1998).
A spectrophotometric technique is always an acceptable alter-
native chemical analysis method, because of its acceptable pre-
cision and accuracy, associated with its lower cost compared to
other techniques.
Multivariate spectral calibrations are also new standard
methods for performing quantitative spectral analysis. Among
the different regression methods existing for multivariate cali-
bration, the factor analysis based methods including partial
least squares (PLS) regression and principal component regres-
sion (PCR) have received considerable attention in chemomet-
rics (Martens and Naes, 1989). PLS and PCR perform data
decomposition into spectral loadings and scores before model
building with the aid of these new variables. In PCR, the data
decomposition is done using only spectral information, while
PLS employs spectral and concentration data. These tech-
niques are powerful multivariate statistical tools that have been
successfully and widely used in the quantitative analysis of
spectroscopic data. They are strong enough to overcome com-
mon statistical problems such as co linearity, band overlaps and
interactions (Martens and Naes, 1989; Boyce, 2001; Cohen
et al., 1987; Deforce et al., 1996; Geldart and Brown, 1998).This study aims to use PCR and PLS to develop a suitable
method for simultaneous spectrophotometric determination of
CYT, THY and URA.
2. Experimental
2.1. Chemicals
All the used chemicals were of analytical reagent grade.
Throughout the experiments, double distilled water was used.
CYT, THY and URA were purchased from Fluka, while tri-
chloroacetic acid was supplied from Merck. The stock solu-
tions of CYT, THY and URA were prepared daily, by
dissolving them in a buffer solution (pH = 7.0) that was pre-
pared by KH2PO4 and NaOH (Merck).
2.2. Instrumentation and software
Electronic absorption measurements were carried out on a Jas-
co v-570 spectrophotometer (slit width: 1.0 nm, scan rate:
2000 cm/min) using 1.00 cm quartz cells. Measurements of
pH were made with a Metrohm 692 pH meter using a com-
bined electrode. All spectra were digitized and stored at wave-
lengths from 220 to 320 nm in steps of 1 nm and then
transferred in TXT format to a Pentium 4, 2.4 GHz computer
using MATLAB software, version 7 (The Math Works). PCR
and PLS calculuses were carried out in the PLS Tool box
(Eigenvector Company, Version 2.5).
2.3. Procedure
2.3.1. Calibration set
A mixture design for three components was used for calibra-
tion set. To provide good prediction in PCR and PLS method,
a training set of 36 samples was taken (Table 1). The concen-
trations of CYT, THY and URA were varied between 1.11–
27.78, 1.26–25.22 and 1.12–22.42 lg mL1, respectively. The
mixed standard solutions were placed in a 10 ml volumetric
ﬂask and completed to ﬁnal volume with buffer solution
(pH= 7.0). Finally the absorption spectra of all prepared
solutions were recorded between 220 and 320 nm against a
blank of universal buffer.
2.3.2. Prediction set
10 mixtures were prepared randomly for prediction set but due
to employing as an independent test, concentrations were not
present in the previous set. Table 2 depicts the solutions used
for prediction set. The range added to be 3.33–24.45, 2.52–
21.44 and 1.79–17.04 lg mL1 for CYT, THY and URA
respectively.
2.4. Real sample preparation
2.4.1. Serum and plasma samples
The serum and plasma samples were homogenized. For depro-
teinization, 1 ml of 24% w/v trichloroacetic acid was added
to1 ml of serum and 1 ml of plasma. After 15 min, the resulting
mixtures were centrifuged at 3000 rpm (Khajehshariﬁ and
Eskandari, 2009). The pH of supernatant solution was ﬁxed
on pH= 7.0 by some amount of NaOH solution. Afterward,
the appropriate amount from the stock solution of CYT, THY
Table 2 Added and founded results of the synthetic mixture of CYT, THY and URA for PLS and PCR.
Mixtures Add (lg/ml) Found (lg/ml) Recovery (%)
URA CYT THY URA CYT THY URA CYT THY
PLS
1 6.72 17.78 2.52 7.03 17.94 2.66 104.61 100.90 105.56
2 11.21 24.45 18.92 11.86 24.13 18.26 105.8 98.69 96.51
3 1.79 10.00 6.31 1.68 9.78 6.28 93.85 97.80 99.52
4 5.60 3.33 21.44 5.37 3.55 21.98 95.89 106.61 102.52
5 13.45 6.67 12.61 13.29 6.36 12.83 98.81 95.35 101.74
6 7.85 21.20 10.09 7.98 21.66 9.85 101.66 102.17 97.62
7 17.04 12.00 11.98 17.37 12.01 12.23 101.94 100.08 102.09
8 3.20 14.00 8.30 3.30 14.11 8.22 103.13 100.79 99.04
9 9.00 8.20 14.10 9.71 8.02 15.15 107.89 97.80 107.45
10 14.80 19.80 16.20 16.12 20.19 16.95 108.92 101.97 104.63
PCR
1 6.72 17.78 2.52 6.08 18.49 2.32 90.48 103.99 92.06
2 11.21 24.45 18.92 10.19 25.27 19.48 90.90 103.35 102.96
3 1.79 10.00 6.31 1.66 9.54 6.39 92.74 95.40 101.27
4 5.60 3.33 21.44 5.86 3.22 20.39 104.64 96.70 95.10
5 13.45 6.67 12.61 14.21 7.09 14.05 105.65 106.30 111.42
6 7.85 21.20 10.09 7.72 21.87 10.81 98.34 103.16 107.14
7 17.04 12.00 11.98 17.82 12.26 11.93 104.58 102.17 99.58
8 3.20 14.00 8.30 3.30 14.35 8.33 103.13 102.50 100.36
9 9.00 8.20 14.10 9.71 8.28 14.13 107.89 100.98 100.21
10 14.80 19.80 16.20 16.12 20.41 16.23 108.92 103.08 100.19
Table 1 Concentration data of mixtures that are used in the calibration set for the determination of CYT, THY and URA.
Mixtures URA (lg/ml) CYT (lg/ml) THY (lg/ml) Mixtures URA (lg/ml) CYT (lg/ml) THY (lg/ml)
M1 22.42 1.11 1.26 M19 13.34 1.11 11.48
M2 19.39 4.89 1.26 M20 16.36 1.11 8.07
M3 19.36 7.78 1.26 M21 19.39 1.11 4.67
M4 13.34 12.56 1.26 M22 19.39 23.89 8.07
M5 10.2 16.33 1.26 M23 16.36 23.89 11.48
M6 7.17 20.11 1.26 M24 13.34 23.89 15.01
M7 4.15 23.89 1.26 M25 10.2 23.89 18.41
M8 1.12 27.78 1.26 M26 7.17 23.89 21.82
M9 1.12 23.89 4.67 M27 10.2 20.11 21.82
M10 1.12 20.11 8.07 M28 13.34 20.11 18.41
M11 1.12 16.33 11.48 M29 16.36 20.11 15.01
M12 1.12 12.56 15.01 M30 19.39 20.11 11.48
M13 1.12 7.78 18.41 M31 19.39 16.33 15.01
M14 1.12 4.89 21.82 M32 16.36 16.33 18.41
M15 1.12 1.11 25.22 M33 13.34 16.33 21.82
M16 4.15 1.11 21.82 M34 16.36 12.56 21.82
M17 7.17 1.11 18.41 M35 19.39 12.56 18.41
M18 10.2 1.11 15.01 M36 19.39 7.78 21.82
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plasma. Then it was ﬁlled to the ﬁnal volume (10 ml) with buf-
fer solution to obtain the desired concentration. The electronic
absorption spectrum was recorded in the range of 220–320 nm
against a blank solution of serum and plasma.
2.4.2. Urine sample
The urine sample was diluted 1:3 with double distilled water.
Then cell debris and the particulate matter were removed from
the urine using low-speed centrifugation for 5 min at
1500 rpm. Afterward the pH of the sample was ﬁxed on
pH= 7.0 by some amount of NaOH solution. Then appropri-
ate amount of the stock solution of CYT, THY and URA wasadded to 0.5 ml of the ﬁnal prepared urine and completed to
the ﬁnal volume (10 ml) with buffer solution to obtain the de-
sired concentration. The electronic absorption spectrum was
recorded in the 220–320 nm against a blank of urine (Khajeh-
shariﬁ and Eskandari, 2008).3. Results and discussion
3.1. Spectral characteristics
The electronic absorption spectra of URA, CYT and THY are
shown in Fig. 1. As it can be seen, the spectrum of each com-
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Figure 1 Absorption spectra of URA (6.5 lg ml1), CYT
(6.5 lg ml1), THY (6.5 lg ml1), mixture (URA (19.4 lg ml1),
CYT (7.8 lg ml1), THY (1.3 lg ml1)) at pH 7.0 and T= 273 K.
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Figure 2 Analytical curves for univariate determination of
URA, CYT and THY.
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cannot be analyzed in the presence of each other by a simple
calibration procedure without prior separation. Therefore
multivariate calibration was used to resolve the spectra and
to determine each component in the mixtures. The composi-
tion data of the solutions are listed in Table 1. On spectral
data, it was recorded in the region between 220 and 320 nm
(1.00 nm steps). The same method was performed for valida-
tion, artiﬁcial and unknown samples.
3.2. Univariate calibration
Individual calibration curves were constructed with several
points (Fig. 2), as absorbance versus pyrimidine bases concen-
tration in the range 1.12–22.42, 1.11–27.78 and 1.26–
25.22 lg mL1 for URA, CYT and THY, respectively. The
maximum wavelength of URA is 259, that of CYT is 267
and that of THY is 265. The wavelengths used to make cali-
bration curves were 220–320 nm. Linear regression results, line
equations and R2 are shown in Fig. 2.
3.3. Multivariate calibration and prediction
Multivariate calibration methods such as PCR and PLS re-
quire a suitable experimental design of the standard that be-
longs to the calibration set to provide good prediction. In
this study, the mixture design was used for experimental de-
sign. It is important to use a method of selection that does
not create an underlying correlation among the concentrations
of the components.
3.3.1. Selection of the optimum number of factors
The optimum number of factors (latent variables) to be in-
cluded in the calibration model was determined by computing
the prediction error sum of squares (PRESS) for cross valida-
tion models using a high number of factors (half the number of
total standard + 1), which is deﬁned as follows:
PRESS ¼
Xn
i¼1
ðc^i  ciÞ2 ð1Þ
where ci is the reference concentration for the i th sample and
c^irepresents the estimated concentration (Stone, 1974;
Despagne and Massart, 1997). The cross-validation method
is employed to eliminate only one sample at a time and thenPLS calibrates the remaining standard spectra. By using this
calibration the concentration of the sample left out was pre-
dicted, this process was repeated until each standard left out
once.
One reasonable choice for the optimum number of factors
would be the number that yielded the minimum PRESS. Since
there are a ﬁnite number of samples in the training set, in many
cases the minimum PRESS value causes over-ﬁtting for un-
known samples that were not included in the model. A solution
to this problem has been suggested by Haaland et al. in which
the PRESS values for all previous factors are compared with
the PRESS value at the minimum (Haaland and Thomas,
1988). The F-statistical test can be used to determine the signif-
icance of PRESS values greater than the minimum. The max-
imum number of factors used to calculate the optimum PRESS
was selected and the optimum number of factors obtained by
PCR and PLS model is summarized in Table 3. PLS and its
relation to PCR and heuristic arguments are presented to ex-
plain that PLS needs fewer factors to give optimal prediction
(Helland, 1988). In all cases, the number of factors for the ﬁrst
PRESS values whose F-ratio probability drops below 0.75 was
Table 3 Statistical parameters of the optimized matrix using
the PLS and PCR.
Method Component NPC PRESS RMSEP RSEP (%)
PLS
URA 4 2.9915 0.5469 5.1480
CYT 5 0.7292 0.2700 1.7663
THY 3 2.5876 0.5087 3.7312
PCR
URA 6 2.7902 0.7067 6.6715
CYT 8 2.4827 0.5093 3.2528
THY 5 4.0570 0.6371 4.7094
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Figure 3 Plots of PRESS vs. number of factors by PCR (h) and
PLS (s).
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Figure 4 Plots of predicted concentration vs. actual concentra-
tion of URA, CYT and THY by PLS.
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by PCR and PLS are shown in Fig. 3.
3.3.2. Statistical parameters
To evaluate the predictive ability of a multivariate calibration
model, the root mean square error of prediction (RMSEP) and
relative standard error of prediction (RSEP) can be used Lin
et al., 1997:RMSEP ¼ 1
n
Xn
i¼1
ðcpred  cobsÞ2
" #0:5
ð2Þ
RSEPð%Þ ¼ 100
Xn
i¼1
ðcpred  cobsÞ2PðcobsÞ2
2
6664
3
7775
0:5
ð3Þ
where cpred and cobs are the predicted concentration and the
observed value of the concentration in the sample, respectively,
and n is the number of samples in the validation set. The values
of RMSEP and RSEP for URA, CYT and THY are summa-
rized in Table 3. In all instances, the values of R2 obtained
are excellent (>0.99).
3.3.3. Resolution of synthetic mixtures
The predictive ability of the method was determined using 10
three-component mixtures (their compositions are given in Ta-
ble 2). The results obtained by applying PCR and PLS algo-
rithm to 10 synthetic samples are listed in Table 2 which also
shows the recovery for the synthetic series of URA, CYT
and THY mixtures. As it can be seen, the recovery was also
acceptable. The plots of the prediction concentration versus
actual values by PLS are shown in Fig. 4 for URA, CYT
and THY (line equations R2 values are also shown).
3.3.4. Determination of URA, CYT and THY in spiked real
samples
To assess the reliability of the method, 6 real sample prepara-
tions were analyzed. Table 4 shows the results as well as the
Table 4 Recoveries of CYT, THY and URA in spiked real samples by PLS.
Mixtures Added (lg/ml) Found (lg/ml) Recovery (%)
URA CYT THY URA CYT THY URA CYT THY
Serum samples
S1 7.85 15.56 6.31 7.96 16.59 6.13 101.40 106.62 97.15
S2 13.45 7.78 11.35 13.26 7.45 12.11 98.59 95.76 106.70
S3 4.48 11.11 17.66 4.26 11.39 17.34 95.09 102.52 98.19
S4 6.72 12.22 11.35 11.97 8.90 4.80 97.08 100.11 95.24
S5 12.33 8.89 5.04 8.18 13.12 12.51 97.27 98.42 99.21
S6 8.41 13.33 12.61 7.96 16.59 6.13 101.40 106.62 97.15
Plasma samples
P1 7.85 15.56 6.31 7.53 15.35 6.24 95.92 98.65 98.89
P2 13.45 7.78 11.35 13.74 7.64 11.30 102.16 98.20 99.56
P3 4.48 11.11 17.66 4.32 10.66 18.34 96.43 95.95 103.85
P4 6.72 12.22 11.35 13.05 9.50 5.01 105.84 106.86 99.40
P5 12.33 8.89 5.04 8.35 13.92 11.83 99.29 104.43 93.81
P6 8.41 13.33 12.61 7.53 15.35 6.24 95.92 98.65 98.89
Urine samples
U1 7.85 15.56 6.31 7.63 15.79 6.46 97.20 101.48 102.38
U2 13.45 7.78 11.35 13.18 7.61 11.04 97.99 97.81 97.27
U3 4.48 11.11 17.66 4.34 11.48 18.49 96.88 103.33 104.70
U4 6.72 12.22 11.35 11.64 8.52 5.06 94.40 95.84 100.40
U5 12.33 8.89 5.04 8.70 13.97 12.42 103.45 104.80 98.49
U6 8.41 13.33 12.61 7.63 15.79 6.46 97.20 101.48 102.38
S146 H. Khajehshariﬁ et al.composition of the real samples. The validation of the method
has been carried out by comparing with the labeled amounts.
As it is clear, the recovery was quantitative and there were
no signiﬁcant differences between the amounts obtained from
this method and the labeled amounts.
4. Conclusions
This study aimed to determine the amount of pyrimidine bases
(i.e., uracil, cytosine and thymine) while they are mixed to-
gether. The overlapping of signals corresponding to the mix-
ture made it necessary to use multivariate analysis tools
including principal component regression or partial least
squares to determine each pyrimidine base separately in their
mixture. PLS seems to get its optimal prediction with fewer
factors than PCR. Besides, PLS reaches better values of the
PRESS, RMSEP and relative RSEP. Also unlike PCR, the
PLS method gives a unique way of choosing which factor to
include next. The results on data sets of URA, CYT and
THY mixtures demonstrate that the predictive ability of the
models obtained was very good and satisfactory. It can be con-
cluded that the spectrophotometric method which was used in
this study is more simple and inexpensive. The good agreement
clearly shows the utility of this procedure in simultaneous spec-
trophotometric determination of URA, CYT and THY in hu-
man serum, human urine and plasma samples.
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